Human HK1 (Hexokinase 1) knockout HEK-293T cell lysate
Be the first to review this product! Submit a review
|
(0 Publication)
HK1 KO cell lysate available now. KO validated by Western blot. Free of charge wild type control included. Knockout achieved by using CRISPR/Cas9, 1 bp insertion in exon10.
View Alternative Names
BB404130, Brain form hexokinase, DrHXK1, EC 2.7.1.1, Glycolytic enzyme, HEXOKIN, HK I, HK1, HK1-ta, HK1-tb, HK1-tc, HMSNR, HXK1_HUMAN, Hexokinase PI, Hexokinase type I, Hexokinase, tumor isozyme, Hexokinase-1, Hexokinase-A, Hk1-s, dea, hexokinase I, im:7148527, mHk1-s, wu:fc09d08, wu:fc16e02, wu:fc21e02, wu:fq14b11, zgc:55790, zgc:77618
- WB
Unknown
Western blot - Human HK1 (Hexokinase 1) knockout HEK-293T cell lysate (AB257161)
Lane 1 : Wild-type HEK293T cell lysate (20 μg)
Lane 2 : HK1 knockout HEK293T cell lysate (20 μg)
Lane 3 : MCF7 cell lysate (20 μg)
Lane 4 : HepG2 cell lysate (20 μg)
Lanes 1-4 : Merged signal (red and green). Green - ab154839 observed at 102 kDa. Red - loading control, ab8245 observed at 37 kDa.
ab154839 Anti-Hexokinase 1 antibody [EPR10135(B)] was shown to specifically react with Hexokinase 1 in wild-type HEK293T cells. Loss of signal was observed when knockout cell line ab267279 (knockout cell lysate ab257161) was used. Wild-type and Hexokinase 1 knockout samples were subjected to SDS-PAGE. ab154839 and Anti-GAPDH antibody [6C5] - Loading Control (ab8245) were incubated overnight at 4°C at 1 in 1000 dilution and 1 in 20000 dilution respectively. Blots were developed with Goat anti-Rabbit IgG H&L (IRDye® 800CW) preadsorbed (ab216773) and Goat anti-Mouse IgG H&L (IRDye® 680RD) preadsorbed (ab216776) secondary antibodies at 1 in 10000 dilution for 1 hour at room temperature before imaging.
All lanes:
Western blot - Anti-Hexokinase 1 antibody [EPR10135(B)] (<a href='/en-us/products/primary-antibodies/hexokinase-1-antibody-epr10135b-ab154839'>ab154839</a>) at 1/1000 dilution
Lane 1:
Wild-type HEK293T cell lysate at 20 µg
Lane 2:
HK1 knockout HEK293T cell lysate at 20 µg
Lane 3:
MCF7 cell lysate at 20 µg
Lane 4:
HepG2 cell lysate at 20 µg
Predicted band size: 102 kDa
Observed band size: 102 kDa
false
- WB
Unknown
Western blot - Human HK1 (Hexokinase 1) knockout HEK-293T cell lysate (AB257161)
Lane 1 : Wild-type HEK293T cell lysate (20 μg)
Lane 2 : HK1 knockout HEK293T cell lysate (20 μg)
Lane 3 : MCF7 cell lysate (20 μg)
Lane 4 : HepG2 cell lysate (20 μg)
Lanes 1-4 : Merged signal (red and green). Green - ab150423 observed at 102 kDa. Red - loading control, ab8245 observed at 37 kDa.
ab150423 Anti-Hexokinase 1 antibody [EPR10134(B)] - Mitochondrial was shown to specifically react with Hexokinase 1 in wild-type HEK293T cells. Loss of signal was observed when knockout cell line ab267279 (knockout cell lysate ab257161) was used. Wild-type and Hexokinase 1 knockout samples were subjected to SDS-PAGE. ab150423 and Anti-GAPDH antibody [6C5] - Loading Control (ab8245) were incubated overnight at 4°C at 1 in 1000 dilution and 1 in 20000 dilution respectively. Blots were developed with Goat anti-Rabbit IgG H&L (IRDye® 800CW) preadsorbed (ab216773) and Goat anti-Mouse IgG H&L (IRDye® 680RD) preadsorbed (ab216776) secondary antibodies at 1 in 10000 dilution for 1 hour at room temperature before imaging.
All lanes:
Western blot - Anti-Hexokinase 1 antibody [EPR10134(B)] - Mitochondrial Outer Membrane Marker (<a href='/en-us/products/primary-antibodies/hexokinase-1-antibody-epr10134b-mitochondrial-outer-membrane-marker-ab150423'>ab150423</a>) at 1/1000 dilution
Lane 1:
Wild-type HEK293T cell lysate at 20 µg
Lane 2:
HK1 knockout HEK293T cell lysate at 20 µg
Lane 3:
MCF7 cell lysate at 20 µg
Lane 4:
HepG2 cell lysate at 20 µg
Predicted band size: 102 kDa
Observed band size: 102 kDa
false
- Sanger seq
Unknown
Sanger Sequencing - Human HK1 (Hexokinase 1) knockout HEK-293T cell lysate (AB257161)
Homozygous : 1 bp insertion in exon10
Reactivity data
Product details
Knockout cell lysate achieved by CRISPR/Cas9.
REACH authorisation
Abcam has not and does not intend to apply for the REACH Authorisation of customers' uses of products that contain European Authorisation list (Annex XIV) substances.
It is the responsibility of our customers to check the necessity of application of REACH Authorisation, and any other relevant authorisations, for their intended uses.
Lysate preparation: Our lysates are made using RIPA buffer to which we add a protease inhibitor cocktail and phosphatase inhibitor cocktail (ratio: 300:100:10). This means that the protein of interest is denatured. If you require a native form of the protein please use the live cell version. Please refer to our lysis protocol for further details on how our lysates are prepared.
User storage instructions: Lyophilizate may be stored at 4°C. After reconstitution, store at -20°C for short-term storage or -80°C for long-term storage.
This product is subject to limited use licenses from The Broad Institute, ERS Genomics Limited and Sigma-Aldrich Co. LLC, and is developed with patented technology. For full details of the licenses and patents please refer to our limited use license and patent pages.
What's included?
Properties and storage information
Gene name
Gene editing type
Gene editing method
Knockout validation
Shipped at conditions
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Quality control
STR analysis
CSF1PO, D13S317, D7S820, D5S818, TH01, D16S539, TPOX
Cell culture
Biosafety level
EU: 2 US: 2
Adherent/suspension
Adherent
Gender
Female
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com